Journals / Turkish Journal of Endocrinology and Metabolism / 2018 / Cilt: 22 - Sayı: 4

The Relationship Between the Level of Parathormone and the Existence and the Degree of Coronary Atherosclerosis

Koroner Ateroskleroz Varlığı ve Derecesi ile Serum Parathormon Düzeyi Arasındaki İlişki

Pages
237–243
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Lastly, when the patients were divided by theparathormone levels into three tertiles and compared withGensini scores, no significant relationship was observed.Conclusion: No relationship was observed between the parathormonelevels and coronary atherosclerosis variables indicatingthat parathormone may not affect coronaryatherosclerosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:An elevated level of parathormone, which is themajor regulator of bone and mineral metabolism, has detrimentaleffects on the heart and vascular system.
📊
Key Findings & Data:In thisstudy, we investigated the relationship between the risk anddegree of coronary atherosclerosis and parathormone levels.Material and Methods: A total number of 77 patients wereincluded in the study.
💡
Conclusion & Impact:Lastly, when the patients were divided by theparathormone levels into three tertiles and compared withGensini scores, no significant relationship was observed.Conclusion: No relationship was observed between the parathormonelevels and coronary atherosclerosis variables indicatingthat parathormone may not affect coronaryatherosclerosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

An elevated level of parathormone, which is themajor regulator of bone and mineral metabolism, has detrimentaleffects on the heart and vascular system. In thisstudy, we investigated the relationship between the risk anddegree of coronary atherosclerosis and parathormone levels.Material and Methods: A total number of 77 patients wereincluded in the study. Serum levels of parathormone, calcium,albumin, phosphorus, and 25-OH vitamin D wereanalyzed in the samples collected pre-operatively from thepatients who underwent elective coronary angiography. Theseverity and diffusiveness of coronary atherosclerosis werecalculated from the angiographic images using Gensiniscore. Pearson's correlation test and logistic regression wereused to analyze the correlation between parathormone levelsand the Gensini scores.Results: No significant relationship was observed betweenPTH values and Gensini scores. When the patients’ Gensiniscores were grouped as smaller and greater than 20 andthen compared with the other variables individually, a positivecorrelation with the corrected calcium levels and 25-OHvitamin D levels was observed. In multivariate analysis,none of the compared variables showed a relationship withGensini score. Lastly, when the patients were divided by theparathormone levels into three tertiles and compared withGensini scores, no significant relationship was observed.Conclusion: No relationship was observed between the parathormonelevels and coronary atherosclerosis variables indicatingthat parathormone may not affect coronaryatherosclerosis.

Özet

Kemik ve mineral metabolizmasının majör düzenleyicisi olan parathormon düzeylerinin artmasının, kalp ve damar sistemi üzerine de etkileri olduğu bilinmektedir. Bu çalışmada, kesitsel olarak koroner ateroskleroz varlığı ve yaygınlığı ile serum parathormon düzeyleri arasında ilişki olup olmadığının araştırılması amaçlanmıştır. Gereç ve Yöntemler: Çalışmamıza toplam 77 hasta alındı. Koroner arter hastalığı şüphesiyle elektif anjiyografi kararı verilen hastanın işlem öncesi alınan kan örneklerinden parathormon, kalsiyum, albumin, fosfor ve 25-OH D3 düzeyleri çalışıldı. Anjiyografi görüntülerinden Gensini skorları hesaplanarak koroner ateroskleroz yaygınlığı ve şiddeti hesaplandı. Pearson korelasyon ve lojistik regresyon analizleri kullanılarak parathormon ve Gensini skorları arasındaki ilişki değerlendirildi. Bulgular: Çalışmamızda, Gensini skoru ile parathormon düzeyleri arasında ilişki saptanmadı. Gensini skoru 20’nin altında ve üzerinde olarak iki gruba ayrılan hastalarda, lojistik regresyon analizi ile değişkenler tek tek incelendiğinde Gensini skorları ile 25-OH D3 düzeyi ve düzeltilmiş kalsiyum düzeyleri ile pozitif korelasyon bulundu. Lojistik regresyon analizi ile Gensini skoru açısından tüm bileşenler birlikte değerlendirildiğinde parathormon, 25-OH D3 vitamini, kalsiyum ve fosfor düzeyleri ile istatistiksel anlamlı bir ilişki saptanmadı. Ayrıca, Gensini skoru ve parathormon düzeyleri üç tertile bölünerek bu gruplar birbirleriyle karşılaştırıldı. Parathormon tertillerinin Gensini skorları arasında anlamlı bir fark saptanmadı. Sonuç: Yapılan analizlerde parathormon düzeyi ve koroner ateroskleroz arasında ilişki saptanmadı. Sonuç olarak, koroner arter hastalığı gelişimi ve ciddiyeti üzerine parathormon düzeyinin etkisi olmayabilmektedir.

🔖

Cite This Article

ÖNCEL, R. C., BALCI, M. K., ÖZDEM, S., SARI, R., BEYPINAR, İ., ALTUNBAŞ, H. (2022). The Relationship Between the Level of Parathormone and the Existence and the Degree of Coronary Atherosclerosis. Turkish Journal of Endocrinology and Metabolism, Cilt: 22 - Sayı: 4, 237–243. https://ajindex.com/articles/605459

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Kumar R, Thompson JR. The regulation of parathyroid hormone secretion and synthesis. J Am Soc Nephrol. 2011;22:216-224.
  2. Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease--a review. Eur Hear J. 2004;25:1776-1787.
  3. Schmermund A, Möhlenkamp S, Erbel R. Coronary artery calcium and its relationship to coronary artery disease. Cardiol Clin. 2003;21:521-534.
  4. Smith JC, Page MD, John R, Wheeler MH, Cockcroft JR, Scanlon MF, Davies JS. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2000;85:3515- 3519. Ureña P, Kong XF, Abou-Samra AB, Jüppner H, Kronenberg HM, Potts JT Jr, Segre GV. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology. 1993;133:617- 623. Neunteufl T, Katzenschlager R, Abela C, Kostner K, Niederle B, Weidinger F, Stefenelli T. Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res. 1998;40:396- 401. Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesario F, Borretta G. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf). 1999;50:321-328.
  5. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med. 1993;95:197-202. Hedbäck G, Tisell LE, Bengtsson BA, Hedman I, Oden A. Premature death in patients operated on for primary hyperparathyroidism. World J Surg. 1990;14:829-835. Hedbäck G, Odén A. Increased risk of death from primary hyperparathyroidism--an update. Eur J Clin Invest. 1998;28:271-276.
  6. Dyadyk OI, Bagriy AE, Yarovaya NF. Disorders of left ventricular structure and function in chronic uremia: how often, why and what to do with it? Eur J Heart Fail. 1999;4:327-336.
  7. Locatelli F, Bommer J, London GM, Martín-Malo A, Wanner C, Yaqoob M, Zoccali C. Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrol Dial Transplant. 2001;16:459-468. Rostand SG. Coronary heart disease in chronic renal insufficiency: some management considerations. J Am Soc Nephrol. 2000;11:1948-1956.
  8. Garcia de la Torre N, Wass JA, Turner HE. Parathyroid adenomas and cardiovascular risk. Endocr Relat Cancer. 2003;10:309-322.
  9. Jorde R, Bonaa KH. Calcium from dairy products, vitamin D intake, and bloo